Segall Bryant & Hamill LLC Cuts Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Segall Bryant & Hamill LLC lowered its position in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 50.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 148,433 shares of the company's stock after selling 151,005 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.12% of Surgery Partners worth $3,525,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Janus Henderson Group PLC boosted its position in Surgery Partners by 110.2% during the fourth quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock valued at $244,616,000 after buying an additional 6,057,477 shares during the period. King Street Capital Management L.P. boosted its position in Surgery Partners by 93.1% during the fourth quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock valued at $59,276,000 after buying an additional 1,350,000 shares during the period. Point72 Asset Management L.P. boosted its position in Surgery Partners by 224.7% during the fourth quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock valued at $36,975,000 after buying an additional 1,208,639 shares during the period. American Century Companies Inc. boosted its position in Surgery Partners by 223.9% during the fourth quarter. American Century Companies Inc. now owns 1,399,756 shares of the company's stock valued at $29,633,000 after buying an additional 967,534 shares during the period. Finally, Norges Bank purchased a new stake in Surgery Partners during the fourth quarter valued at about $15,796,000.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on SGRY shares. Royal Bank Of Canada reissued an "outperform" rating and issued a $35.00 price target on shares of Surgery Partners in a research note on Tuesday, March 25th. Benchmark reaffirmed a "buy" rating and set a $35.00 target price on shares of Surgery Partners in a research note on Monday, April 21st. Finally, Barclays cut their price target on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 27th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Surgery Partners currently has an average rating of "Moderate Buy" and an average target price of $33.56.

Surgery Partners Price Performance

Surgery Partners stock traded down $0.30 during mid-day trading on Tuesday, hitting $22.06. 1,804,709 shares of the company were exchanged, compared to its average volume of 1,202,143. The company has a quick ratio of 1.73, a current ratio of 1.89 and a debt-to-equity ratio of 1.09. The business has a fifty day moving average of $22.41 and a 200 day moving average of $22.82. Surgery Partners, Inc. has a 1-year low of $18.87 and a 1-year high of $33.97. The company has a market capitalization of $2.83 billion, a PE ratio of -14.42 and a beta of 1.90.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The firm had revenue of $776.00 million during the quarter, compared to analyst estimates of $777.77 million. During the same quarter in the previous year, the business earned $0.10 earnings per share. Surgery Partners's revenue for the quarter was up 8.2% compared to the same quarter last year. As a group, sell-side analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.